Fiera Capital Corp Buys New Stake in Intuitive Surgical, Inc. $ISRG

Fiera Capital Corp bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 93,137 shares of the medical equipment provider’s stock, valued at approximately $41,654,000.

Other hedge funds also recently bought and sold shares of the company. Tobam lifted its position in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth about $27,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at about $27,000. Riggs Asset Managment Co. Inc. lifted its holdings in Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares in the last quarter. Finally, First Command Advisory Services Inc. lifted its holdings in Intuitive Surgical by 3,750.0% in the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 464 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the completion of the sale, the senior vice president owned 131 shares in the company, valued at approximately $71,852.19. The trade was a 77.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the sale, the director directly owned 15,720 shares of the company’s stock, valued at approximately $8,355,494.40. This trade represents a 15.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 56,189 shares of company stock worth $30,785,441 in the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $504.05 on Friday. The firm has a market capitalization of $179.00 billion, a price-to-earnings ratio of 63.88, a price-to-earnings-growth ratio of 3.87 and a beta of 1.65. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $607.35. The company has a 50 day moving average price of $535.88 and a 200 day moving average price of $510.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter last year, the business earned $2.21 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Sanford C. Bernstein raised their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Royal Bank Of Canada increased their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $617.23.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.